Increased epithelial stem cell traits in advanced endometrial endometrioid carcinoma

BMC Genomics

Volumn 10, Issue , 2009, Pages

  Chang, Shing Jyh ^b,c   Wang, Tao Yeuan ^b,d   Tsai, Chan Yen ^a   Hu, Tzu Fang ^a   Chang, Margaret D ^c   Wang, Hsei Wei ^a,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^e TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN APBA2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; APBA2 PROTEIN, HUMAN; CADHERIN; CARRIER PROTEIN; CCR1 PROTEIN, HUMAN; ERBB2 PROTEIN, HUMAN; NERVE PROTEIN;

ADULT; ADULT STEM CELL; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; EPITHELIAL STEM CELL; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PROGNOSIS; SIGNAL TRANSDUCTION; STEM CELL; BIOLOGY; CYTOLOGY; DNA MICROARRAY; ENDOMETRIUM TUMOR; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, ENDOMETRIOID; CARRIER PROTEINS; COMPUTATIONAL BIOLOGY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ENDOMETRIAL NEOPLASMS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ERBB-2; RECEPTORS, CCR1; STEM CELLS;

EID: 75449097404     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-10-613     Document Type: Article

References (57)

1. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, Morrison SJ. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006, 441(7092):475-482. 10.1038/nature04703, 16598206.
2. Barnhart BC, Simon MC. Metastasis and stem cell pathways. Cancer Metastasis Rev 2007, 26(2):261-271. 10.1007/s10555-007-9053-3, 17647111.
3. Trosko JE. Review paper: cancer stem cells and cancer nonstem cells: from adult stem cells or from reprogramming of differentiated somatic cells. Vet Pathol 2009, 46(2):176-193.
4. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414(6859):105-111. 10.1038/35102167, 11689955.
5. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9(5):391-403. 10.1016/j.ccr.2006.03.030, 16697959.
6. Yang ZJ, Ellis T, Markant SL, Read TA, Kessler JD, Bourboulas M, Schuller U, Machold R, Fishell G, Rowitch DH, Wainwright BJ, Wechsler-Reya RJ. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 2008, 14(2):135-145. 10.1016/j.ccr.2008.07.003, 2538687, 18691548.
7. Schuller U, Heine VM, Mao J, Kho AT, Dillon AK, Han YG, Huillard E, Sun T, Ligon AH, Qian Y, Ma Q, Alvarez-Buylla A, McMahon AP, Rowitch DH, Ligon KL. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 2008, 14(2):123-134. 10.1016/j.ccr.2008.07.005, 2597270, 18691547.
8. Perez-Caro M, Cobaleda C, Gonzalez-Herrero I, Vicente-Duenas C, Bermejo-Rodriguez C, Sanchez-Beato M, Orfao A, Pintado B, Flores T, Sanchez-Martin M, Jimenez R, Piris MA, Sanchez-Garcia I. Cancer induction by restriction of oncogene expression to the stem cell compartment. Embo J 2009, 28(1):8-20. 10.1038/emboj.2008.253, 2600654,2600654, 19037256.
9. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 1999, 400(6743):464-468. 10.1038/22780, 10440377.
10. Kho AT, Zhao Q, Cai Z, Butte AJ, Kim JY, Pomeroy SL, Rowitch DH, Kohane IS. Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev 2004, 18(6):629-640. 10.1101/gad.1182504, 387239, 15075291.
11. Hu M, Shivdasani RA. Overlapping gene expression in fetal mouse intestine development and human colorectal cancer. Cancer Res 2005, 65(19):8715-8722. 10.1158/0008-5472.CAN-05-0700, 16204040.
12. Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, Kong S, Sakthivel B, Xu H, Reichling T, Azhar M, Boivin GP, Roberts RB, Bissahoyo AC, Gonzales F, Bloom GC, Eschrich S, Carter SL, Aronow JE, Kleimeyer J, Kleimeyer M, Ramaswamy V, Settle SH, Boone B, Levy S, Graff JM, et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 2007, 8(7):R131. 10.1186/gb-2007-8-7-r131, 2323222, 17615082.
13. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008, 40(5):499-507. 10.1038/ng.127, 18443585.
14. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133(4):704-715. 10.1016/j.cell.2008.03.027, 2728032, 18485877.
15. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008, 3(8):e2888. 10.1371/journal.pone.0002888, 2492808, 18682804.
16. Liu FS. Molecular carcinogenesis of endometrial cancer. Taiwan J Obstet Gynecol 2007, 46(1):26-32. 10.1016/S1028-4559(08)60102-3, 17389185.
17. Sorosky JI. Endometrial cancer. Obstet Gynecol 2008, 111(2 Pt 1):436-447.
18. Barker N, Ridgway RA, van Es JH, Wetering M, Begthel H, Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457(7229):608-611. 10.1038/nature07602, 19092804.
19. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT, Poppleton H, Zakharenko S, Ellison DW, Gilbertson RJ. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009, 457(7229):603-607. 10.1038/nature07589, 2633030, 19092805.
20. Flier LG, Haegebarth A, Stange DE, Wetering M, Clevers H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 2009, 137(1):15-17. 10.1053/j.gastro.2009.05.035, 19450592.
21. Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Makinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 2004, 36(7):687-693. 10.1038/ng1384, 15220918.
22. Huang TS, Hsieh JY, Wu YH, Jen CH, Tsuang YH, Chiou SH, Partanen J, Anderson H, Jaatinen T, Yu YH, Wang HW. Functional network reconstruction reveals somatic stemness genetic maps and dedifferentiation-like transcriptome reprogramming induced by GATA2. Stem Cells 2008, 26(5):1186-1201. 10.1634/stemcells.2007-0821, 18308945.
23. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286(5439):531-537. 10.1126/science.286.5439.531, 10521349.
24. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003, 33(1):49-54. 10.1038/ng1060, 12469122.
25. Jen CH, Yang TP, Tung CY, Su SH, Lin CH, Hsu MT, Wang HW. Signature Evaluation Tool (SET): a Java-based tool to evaluate and visualize the sample discrimination abilities of gene expression signatures. BMC Bioinformatics 2008, 9(1):58. 10.1186/1471-2105-9-58, 2248562, 18221568.
26. Shabo I, Stal O, Olsson H, Dore S, Svanvik J. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer 2008, 123(4):780-786. 10.1002/ijc.23527, 18506688.
27. Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 2008, 216(1):15-24. 10.1002/path.2370, 18553315.
28. Uharcek P. Prognostic factors in endometrial carcinoma. J Obstet Gynaecol Res 2008, 34(5):776-783. 10.1111/j.1447-0756.2008.00796.x, 18958927.
29. Grushko TA, Filiaci VL, Mundt AJ, Ridderstrale K, Olopade OI, Fleming GF. An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2008, 108(1):3-9. 10.1016/j.ygyno.2007.09.007, 2699629, 17945336.
30. Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Kos J, Skrk J. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2000, 6(3):1052-1062.
31. Byers RJ, Sakhinia E, Joseph P, Glennie C, Hoyland JA, Menasce LP, Radford JA, Illidge T. Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. Blood 2008, 111(9):4764-4770. 10.1182/blood-2007-10-115915, 18174380.
32. Salvesen HB, Akslen LA. Molecular pathogenesis and prognostic factors in endometrial carcinoma. APMIS 2002, 110(10):673-689. 10.1034/j.1600-0463.2002.1101001.x, 12583434.
33. An C, Choi IS, Yao JC, Worah S, Xie K, Mansfield PF, Ajani JA, Rashid A, Hamilton SR, Wu TT. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res 2005, 11(2 Pt 1):656-663.
34. Toyota M, Kopecky KJ, Toyota MO, Jair KW, Willman CL, Issa JP. Methylation profiling in acute myeloid leukemia. Blood 2001, 97(9):2823-2829. 10.1182/blood.V97.9.2823, 11313277.
35. Bieche I, Lerebours F, Tozlu S, Espie M, Marty M, Lidereau R. Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clin Cancer Res 2004, 10(20):6789-6795. 10.1158/1078-0432.CCR-04-0306, 15501955.
36. Skibbens RV. Cell biology of cancer: BRCA1 and sister chromatid pairing reactions?. Cell Cycle 2008, 7(4):449-452.
37. Juric D, Sale S, Hromas RA, Yu R, Wang Y, Duran GE, Tibshirani R, Einhorn LH, Sikic BI. Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. Proc Natl Acad Sci USA 2005, 102(49):17763-17768. 10.1073/pnas.0509082102, 1308932, 16306258.
38. Kho DH, Bae JA, Lee JH, Cho HJ, Cho SH, Seo YW, Ahn KY, Chung IJ, Kim KK. KITENIN recruits Dishevelled/PKC delta to form a functional complex and controls the migration and invasiveness of colorectal cancer cells. Gut 2009, 58(4):509-519. 10.1136/gut.2008.150938, 18653728.
39. Birnie R, Bryce SD, Roome C, Dussupt V, Droop A, Lang SH, Berry PA, Hyde CF, Lewis JL, Stower MJ, Maitland NJ, Collins AT. Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol 2008, 9(5):R83. 10.1186/gb-2008-9-5-r83, 2441469, 18492237.
40. Arribas J, Esselens C. ADAM17 as a therapeutic target in multiple diseases. Curr Pharm Des 2009, 15(20):2319-2335. 10.2174/138161209788682398, 19601834.
41. Yamazaki K, Takamura M, Masugi Y, Mori T, Du W, Hibi T, Hiraoka N, Ohta T, Ohki M, Hirohashi S, Sakamoto M. Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility. Lab Invest 2009, 89(4):425-432. 10.1038/labinvest.2009.5, 19188911.
42. Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, Prime W, Campbell F, Dodson A, Jenkins RE, Lemoine NR, Crnogorac-Jurcevic T, Yin HL, Costello E. Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut 2007, 56(1):95-106. 10.1136/gut.2005.083691, 1856675, 16847067.
43. Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol 2007, 6(3):237-244. 10.1016/S1474-4422(07)70053-4, 17303530.
44. Ma X, Zhao H, Shan J, Long F, Chen Y, Zhang Y, Han X, Ma D. PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. Mol Biol Cell 2007, 18(6):1965-1978. 10.1091/mbc.E06-07-0608, 1877091, 17360971.
45. Lu Y, Lemon W, Liu PY, Yi Y, Morrison C, Yang P, Sun Z, Szoke J, Gerald WL, Watson M, Govindan R, You M. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med 2006, 3(12):e467. 10.1371/journal.pmed.0030467, 1716187,1716187, 17194181.
46. Chiu SY, Asai N, Costantini F, Hsu W. SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages. PLoS Biol 2008, 6(12):e310. 10.1371/journal.pbio.0060310, 2602722,2602722, 19090619.
47. Hoffman AE, Zheng T, Ba Y, Zhu Y. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res 2008, 6(9):1461-1468. 10.1158/1541-7786.MCR-07-2094, 2572675, 18819933.
48. Deshpande AM, Akunowicz JD, Reveles XT, Patel BB, Saria EA, Gorlick RG, Naylor SL, Leach RJ, Hansen MF. PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumors. Oncogene 2007, 26(12):1714-1722. 10.1038/sj.onc.1209988, 2691996, 17001316.
49. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJ, Yang PC. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007, 356(1):11-20. 10.1056/NEJMoa060096, 17202451.
50. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Li KC, Chen JJ, Yang PC. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13(1):48-57. 10.1016/j.ccr.2007.12.008, 18167339.
51. Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 2003, 100(26):15901-15905. 10.1073/pnas.2634067100, 307665, 14665696.
52. Podsypanina K, Du YC, Jechlinger M, Beverly LJ, Hambardzumyan D, Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 2008, 321(5897):1841-1844. 10.1126/science.1161621, 2694414, 18755941.
53. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmuller G, Klein CA. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13(1):58-68. 10.1016/j.ccr.2007.12.003, 18167340.
54. Chang SJ, Huang TS, Wang KL, Wang TY, Yang YC, Chang MD, Wu YH, Wang HW. Genetic network analysis of human CD34+ hematopoietic stem/precursor cells. Taiwanese Journal of Obstetrics & Gynecology 2008, 47(4):422-430. 10.1016/S1028-4559(09)60010-3, 19126509.
55. Yang TP, Chang TY, Lin CH, Hsu MT, Wang HW. ArrayFusion: a web application for multi-dimensional analysis of CGH, SNP and microarray data. Bioinformatics 2006, 22(21):2697-2698. 10.1093/bioinformatics/btl457, 16935928.
56. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C, Richter J, Rubin GM, Blake JA, Bult C, Dolan M, Drabkin H, Eppig JT, Hill DP, Ni L, Ringwald M, Balakrishnan R, Cherry JM, Christie KR, Costanzo MC, Dwight SS, Engel S, Fisk DG, Hirschman JE, Hong EL, Nash RS, et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004, (32 Database):D258-261. 308770, 14681407.
57. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4(5):P3. 10.1186/gb-2003-4-5-p3, 12734009.